Humacyte HUMA
NASDAQ HUMA
$0.44 +0.02 (+5.40%)
At close: Oct 23, 2026 · 4:00 PM EDT

Humacyte (HUMA) Asset Utilization Ratio (2024 - 2026)

Updated

Humacyte's (HUMA) Asset Utilization Ratio stood at 0.02 in Q2 2026, up 214.3% from 0.01 a year earlier but down 4.0% from the prior quarter.

Analysis

Humacyte (HUMA) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Starting with Q2 2024, Humacyte's Asset Utilization Ratio history includes 8 quarters.

  • Quarterly Asset Utilization Ratio has ranged from 0.00 in Q3 2024 to 0.02 in Q4 2025 over the past five years.
  • On a year-over-year basis, Asset Utilization Ratio rose in three of the last four quarters, with growth averaging 304.3%.
  • Per Business Quant, the preceding three quarters came in at 0.02 (Q1 2026), 0.02 (Q4 2025) and 0.01 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 0.62
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 0.50
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 0.47
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 0.52
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 0.46
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 0.51
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 0.40
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.58
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 0.31
10 Humacyte 101.19 Mn -97.25 Mn -825,000.00 0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Mar 31, 2026 0.02
Dec 31, 2025 0.02
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.01
API Access

Humacyte Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=HUMA&period=max&api_key=YOUR_API_KEY